Merck & Co (MRK) Akcie Kurz
Merck & Co Kurz
Cena akcie Merck & Co
Tato data přes Eulerpool API
100 000 požadavků/měs. zdarma · bez karty
Obchodní model Merck & Co a analýza akcií
Nejčastější otázky týkající se akcie Merck & Co
The business model of Merck & Co Inc is centered around the development, manufacturing, and marketing of innovative pharmaceutical products and vaccines. Merck's primary aim is to improve and save lives by addressing unmet medical needs. Through rigorous research and development, the company focuses on discovering novel therapies and delivering them to patients worldwide. Merck operates across various therapeutic areas, including oncology, infectious diseases, vaccines, cardiovascular health, and more. By combining scientific expertise with a strong commitment to patients and healthcare professionals, Merck continually strives to advance medical science and make a positive impact on global health.
Merck & Co Inc is primarily active in the pharmaceutical and healthcare industries.
The main competitors of Merck & Co Inc in the market are Johnson & Johnson, Pfizer Inc, Novartis AG, and Bristol-Myers Squibb Company.
Merck & Co Inc is a renowned pharmaceutical company with a rich history and notable background. Established in 1891, Merck & Co Inc has been dedicated to enhancing global health and improving people's lives. The company has evolved into one of the leading players in the pharmaceutical industry, specializing in research, development, and manufacturing of innovative medications and vaccines. Merck & Co Inc has proactively contributed to medical advancements, from pioneering treatments for diseases like HIV/AIDS to addressing various health challenges. With a commitment to scientific excellence and patient well-being, Merck & Co Inc continues to shape the future of healthcare worldwide.
Merck & Co Inc, a leading pharmaceutical company, has achieved significant milestones throughout its history. The company's notable achievements include the development and launch of groundbreaking drugs like Gardasil, a vaccine for preventing cervical cancer, and Keytruda, an innovative immunotherapy for treating various types of cancer. Merck & Co Inc has also contributed to medical advancements with its research and development efforts, resulting in breakthroughs in areas such as HIV/AIDS treatment and vaccines. The company's commitment to improving global health has resulted in partnerships and initiatives aimed at tackling diseases like malaria and Ebola. Merck & Co Inc continues to make strides in the pharmaceutical industry, focusing on innovative solutions for unmet medical needs.
Merck & Co Inc is primarily present in several countries and regions across the world. The company has a strong global presence, with operations in the United States, Europe, Asia-Pacific, Latin America, and Africa. Merck & Co Inc has established a significant presence in key markets such as the United States, Germany, Japan, China, and Brazil. With its wide international footprint, Merck & Co Inc is committed to delivering its innovative healthcare solutions to patients and healthcare professionals worldwide.
Merck & Co Inc represents a strong commitment to scientific innovation, integrity, and improving global health. As a leading pharmaceutical company, Merck aims to discover, develop, and provide high-quality healthcare solutions. The company's corporate philosophy revolves around putting patients first, valuing diversity and inclusion, and taking responsibility for environmental sustainability. Merck is dedicated to delivering innovative medicines and vaccines, ensuring affordability and access for patients worldwide. With a focus on research, collaboration, and ethical business practices, Merck strives to make a positive impact on society and enhance the well-being of individuals around the globe.
Při aktuálním kurzu se akcie Merck & Co obchoduje za 129,67 EUR (145,27 USD).
Akcie Merck & Co (MRK) je kótována na 11 burzách, mimo jiné: NYSE (MRK), London (0QAH.L), SIX (Zürich) (MRK1.SW), XETRA (6MK.DE), Frankfurt (6MK.F), München (6MK.MU), Düsseldorf (6MK.DU), Hamburg (6MK.HM).
Merck & Co Inc is one of the leading global pharmaceutical companies focused on the discovery, development, and marketing of drugs, vaccines, and biologics for a variety of diseases and disorders. The company is headquartered in Kenilworth, New Jersey and operates worldwide in over 140 countries.
Tržby nelze pro Merck & Co aktuálně vypočítat.
Zisk nelze pro Merck & Co aktuálně vypočítat.
Poměr P/E nelze pro Merck & Co aktuálně vypočítat.
Poměr P/S nelze pro Merck & Co aktuálně vypočítat.
Score kvality nelze pro Merck & Co aktuálně vypočítat.
ISIN Merck & Co je US58933Y1055. ISIN (International Securities Identification Number) je celosvětově jedinečný identifikátor cenných papírů.
WKN Merck & Co je A0YD8Q. WKN (Wertpapierkennnummer) je šestimístný německý identifikační kód cenného papíru.
Ticker Merck & Co je MRK. Symbol tickeru se používá k obchodování akcií Merck & Co na burze.
Merck & Co akcie
Merck & Co Ticker
Merck & Co FIGI
Všechny fundamentální údaje o Merck & Co v podrobné analýze
Naše analýzy akcií společnosti Merck & Co zahrnují důležité finanční ukazatele jako obrat, zisk, P/E poměr, P/S poměr, EBIT, stejně jako informace o dividendách. Dále zkoumáme aspekty jako akcie, tržní kapitalizaci, dluhy, vlastní kapitál a závazky společnosti Merck & Co. Pokud hledáte podrobnější informace o těchto tématech, nabízíme vám na našich podstránkách rozsáhlé analýzy: